Boston, MA, United States of America

Barry Canton

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignee: Iti Scotland Limited. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barry Canton. Retrieved from https://idiyas.com/inventor/barry-canton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Barry Canton

Introduction

Barry Canton is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of molecular biology through his innovative methods for assembling polynucleic acid sequences. With a total of two patents to his name, his work is paving the way for advancements in genetic research and applications.

Latest Patents

Canton's latest patents include a "Method for the assembly of a polynucleic acid sequence" and a "Method for assembly of polynucleic acid sequences." The first patent provides methods for assembling polynucleic acid sequences on microfluidic devices, preparing libraries of these sequences, and designing nucleic acid sequences. The second patent outlines a detailed process for assembling polynucleic acid sequences from multiple nucleic acid sequences, utilizing complementary oligonucleotide linker sequences to facilitate ligation.

Career Highlights

Barry Canton is currently associated with Iti Scotland Limited, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in genetic engineering and synthetic biology.

Collaborations

Canton has collaborated with notable colleagues such as Austin Che and Tom Knight, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Barry Canton's contributions to the field of molecular biology through his patents and collaborations highlight his role as a leading inventor in the biotechnology sector. His innovative methods are set to influence future research and applications in genetic science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…